Cases & Deals

Merz GmbH acquires Pharma Investment Holding

Clients Merz GmbH & Co. KGaA

Jones Day advised Merz GmbH & Co. KGaA in its acquisition of Pharma Investment Holding S.A. which holds a 100% share in BioteCon Therapeutics GmbH.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.